Capsensixx AG (FRA:CPX) Change In Receivables: €-18.9 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:CPX Capsensixx AG FRA:CPX
91 GF Score
Price €21.00
GF Value €27.81
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Capsensixx AG Change In Receivables?

Capsensixx AG FRA:CPX 91 Change In Receivables is €-18.9 Mil as of Dec. 2025. GuruFocus rates FRA:CPX with a GF Score™ of 91/100 and a GF Value™ of €27.81 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Capsensixx AG's change in receivables for the quarter that ended in Dec. 2025 was €-27.6 Mil. It means Capsensixx AG's Accounts Receivable increased by €27.6 Mil from Jun. 2025 to Dec. 2025 .

Capsensixx AG's change in receivables for the fiscal year that ended in Dec. 2025 was €-18.9 Mil. It means Capsensixx AG's Accounts Receivable increased by €18.9 Mil from Dec. 2024 to Dec. 2025 .

Capsensixx AG's Accounts Receivable for the quarter that ended in Dec. 2025 was €45.2 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Capsensixx AG's Days Sales Outstanding for the six months ended in Dec. 2025 was 69.91.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Capsensixx AG's liquidation value for the six months ended in Dec. 2025 was €3.7 Mil.

Capsensixx AG  (FRA:CPX) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Capsensixx AG's Days Sales Outstanding for the quarter that ended in Dec. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=45.229/118.078*91
=69.91

2. In Ben Graham's calculation of liquidation value, Capsensixx AG's accounts receivable are only considered to be worth 75% of book value:

Capsensixx AG's liquidation value for the quarter that ended in Dec. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=22.286-52.485+0.75 * 45.229+0.5 * 0
=3.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Capsensixx AG Change In Receivables Related Terms

Capsensixx AG Change In Receivables Historical Data

* Premium members only.

The historical data trend for Capsensixx AG's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Capsensixx AG Change In Receivables Chart

Capsensixx AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -43.93 60.59 -5.49 -9.98 -18.93

Capsensixx AG Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.95 0.59 -10.57 8.64 -27.57
FRA:CPX
91GF Score
Capsensixx AG FRA:CPX
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Capsensixx AG Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-18.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of €-18.9 Mil mean?
Capsensixx AG (FRA:CPX) has a Change In Receivables of €-18.9 Mil as of Dec. 2025. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Capsensixx AG and its competitors.
Is Capsensixx AG's Change In Receivables too high?
Capsensixx AG's current Change In Receivables is €-18.9 Mil. Overall, Capsensixx AG has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Capsensixx AG's Change In Receivables compare to BLK and BX?
Capsensixx AG's Change In Receivables of €-18.9 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for an Asset Management company?
A good Change In Receivables depends on the Asset Management industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Capsensixx AG and its competitors. Capsensixx AG's current Change In Receivables is €-18.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Capsensixx AG stock overvalued right now?
Based on GuruFocus' analysis, Capsensixx AG (FRA:CPX) is currently considered Modestly Undervalued. The stock's GF Value™ is €27.81, compared to a current price of €21.00 — trading 24.5% below its estimated fair value. The current Change In Receivables is €-18.9 Mil. Capsensixx AG's overall GF Score™ is 91/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Capsensixx AG (FRA:CPX), the current Change In Receivables is €-18.9 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Capsensixx AG (FRA:CPX) Overvalued in 2026?

Based on GuruFocus' analysis, Capsensixx AG stock appears to be undervalued. The current stock price of €21.00 is trading 24.5% below its estimated GF Value™ of €27.81. GuruFocus considers Capsensixx AG to be Modestly Undervalued.

Key valuation signals for FRA:CPX:

  • Change In Receivables: €-18.9 Mil
  • GF Value™: €27.81 vs. price of €21.00 (24.5% below fair value)
  • GF Score™: 91/100 with 2 warning signs

No single metric tells the full story. See the FRA:CPX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Capsensixx AG Business Description

Other Exchanges CPX:Germany
Address Bettinastrasse 57-59, Frankfurt, DEU, D-60325
Capsensixx AG is a provider of financial administration as a service. The company is divided into two segments namely Funds management, Administration and Accounting Segment which includes fund management and fund accounting; and Securitisations which provides Advisory services in the field of financial engineering, securitisation and provision of director and administrative services to corporate clients in Luxembourg.
91GF Score

Get the complete analysis for FRA:CPX

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.00
Price
€27.81
GF Value